AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21956725
Drug: Clobazam 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam 1.0 mg/kg/day
Trial: 15330492
Drug: Hibiscus sabdariffa
RxNorm normalized name: HIBISCUS SABDARIFFA CALYX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hibiscus sabdariffa extract (10 g dry calyx in 0.51 L water, 9.6 mg anthocyanins)
Trial: 1461544
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg twice a day)
Trial: 11583480
Drug: parecoxib sodium
RxNorm normalized name: parecoxib sodium
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: parecoxib sodium (1 mg, 2 mg, 5 mg, 10 mg, 20 mg, or 40 mg)
Trial: 9720702
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of prednisolone in a monthly oral pulse (Group A, aged 12 to 18 years)
Trial: 9720702
Drug: Betamethasone sodium
RxNorm normalized name: Betamethasone Sodium Phosphate
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone sodium phosphate as soluble tablets or syrup equivalent to prednisolone 5 mg/kg body weight every month (Group B, aged 3 to 11 years)
Trial: 9720702
Drug: Pulsed doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed doses of corticosteroid (both groups)
Trial: 8131343
Drug: alfacalcidol 0.25
RxNorm normalized name: alfacalcidol 0.25 MCG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alfacalcidol 0.25 microgram twice daily with calcium 500 mg twice daily
Trial: 8131343
Drug: placebo twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo twice daily with calcium 500 mg twice daily
Trial: 642493
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g of albumin during operation followed by 150 g/day for 5 days
Trial: 28382336
Drug: Fermented Maillard-reactive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermented Maillard-reactive whey protein (F-MRP) 6 g/day for 8 weeks
Trial: 28382336
Drug: Placebo (maltodextrin)
RxNorm normalized name: Maltodextrin
DrugBank: Maltodextrin (DB12583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (maltodextrin) 6 g/day for 8 weeks
Trial: 21211643
Drug: Timothy grass
RxNorm normalized name: Timothy grass
DrugBank: Phleum pratense top (DB14179)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timothy grass allergy immunotherapy tablet (AIT) treatment
Trial: 20068276
Drug: Micafungin (MCFG)
DrugBank: Micafungin (DB01141)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Micafungin (MCFG) 2 mg/kg/day (max 100 mg/day)
Trial: 20068276
Drug: Fosfluconazole (FF)
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfluconazole (FF) 10 mg/kg/day (max 400 mg/day)
Trial: 17589370
Drug: Dronabinol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronabinol (5 mg)
Trial: 26960406
Drug: Pharmacist intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist intervention with home medication management review
Trial: 24595942
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g dehydrated garlic powder
Trial: 24595942
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g dehydrated garlic powder
Trial: 22265697
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg per day plus goserelin 3.6 mg/month
Trial: 22265697
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg per day plus goserelin 3.6 mg/month
Trial: 20147671
Drug: Insulin use
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin use
Trial: 14989794
Drug: r‐hFSH and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐hFSH and r‐hLH (150 IU daily)
Trial: 14989794
Drug: r‐hFSH and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐hFSH and r‐hLH (150 IU daily) (<35 years)
Trial: 14989794
Drug: r‐hFSH and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐hFSH and r‐hLH (150 IU daily) (≥35 years)
Trial: 11668407
Drug: Sequential combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential combination of pure cut then blended current
Trial: 7905722
Drug: Didanosine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine (600 mg/d adjusted for weight)
Trial: 7905722
Drug: Zidovudine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (600 mg/d)
Trial: 6581281
Drug: Diazepam titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam titration (mean dose = 25.6 mgs)
Trial: 6581281
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diazepam (12.5 mg), fentanyl (0.1 mg), and methohexital (mean dose = 18.0 mg)
Trial: 6581281
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diazepam (15.0 mg) and methohexital (mean dose = 27.0 mg)
Trial: 31905090
Drug: Tolcapone (an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolcapone (an inhibitor of catechol‐O‐methyltransferase [COMT])
Trial: 31905090
Drug: Bromocriptine (a
RxNorm normalized name: Bromocriptine (as bromocriptine mesilate) 1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (a DA agonist with preferential affinity for the D2 receptor)
Trial: 10697061
Drug: Oseltamivir 75
RxNorm normalized name: oseltamivir 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir 75 mg twice daily
Trial: 22039289
Drug: Rimantadine 100
RxNorm normalized name: riMANTAdine 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimantadine 100 mg twice daily
Trial: 22039289
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment of oseltamivir and rimantadine
Trial: 8821690
Drug: Control (monotherapy)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (monotherapy)
Trial: 20054875
Drug: Atypical antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotics (e.g., olanzapine, quetiapine, risperidone)
Trial: 17433007
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose of alcohol (n=26)
Trial: 12874615
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/HCTZ 12.5 mg
Trial: 11890866
Drug: Immunotherapy (vaccines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (vaccines involving monoclonal antibodies or immune effector cells)
Trial: 11890866
Drug: Cell-based therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cell-based therapies using tumour cells as vaccine components
Trial: 11890866
Drug: Immune cells
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immune cells (e.g., T-lymphocytes and dendritic cells)
Trial: 9928553
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg daily for 5 years
Trial: 9815522
Drug: Tamoxifen with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen with chemotherapy
Trial: 334209
Drug: Diazepam (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (7.5 mg and 15 mg)
Trial: 334209
Drug: Hydroxyzine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine (75 mg and 150 mg)
Trial: 25383558
Drug: Multitarget therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multitarget therapy (tacrolimus 4 mg/d and mycophenolate mofetil 1.0 g/d)
Trial: 25383558
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (0.75 g/m2 every 4 weeks for 6 months)
Trial: 23816018
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cTnT with copeptin
Trial: 23816018
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of hs-cTnT with copeptin
Trial: 23816018
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cTnT and copeptin
Trial: 23816018
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of hs-cTnT and copeptin
Trial: 21681372
Drug: Chemoimmunotherapy (NP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoimmunotherapy (NP chemotherapy followed by vaccination with CEA (605-613) peptide-pulsed autologous dendritic cells and CIK cells, repeated at 30-day intervals for 4 cycles)
Trial: 21681372
Drug: Conventional NP
RxNorm normalized name: NP Thyroid Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional NP chemotherapy
Trial: 17276750
Drug: Methylphenidate 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate 0.25 mg/kg
Trial: 9136493
Drug: Methylphenidate 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate 0.5 mg/kg
Trial: 17276750
Drug: Methylphenidate 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate 0.125 mg/kg
Trial: 15352149
Drug: Long-acting risperidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting risperidone (25, 50, or 75 mg every 2 weeks for up to 50 weeks)
Trial: 2968761
Drug: Buserelin (pernasally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin (pernasally in conventional doses)
Trial: 30839075
Drug: CGAE supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGAE supplementation at 1,000 mg/kg
Trial: 23228270
Drug: Apical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical preparation size 35.06 to 40.04
Trial: 23228270
Drug: Apical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical preparation taper from 40.04 to 40.06 in group B
Trial: 23228270
Drug: Apical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical preparation sizes greater than 40.06
Trial: 23228270
Drug: Negative control:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative control: preparation size of 25.04
Trial: 14698362
Drug: Clonidine 1
RxNorm normalized name: apraclonidine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 1 microg.mL(‐1) at rate of 0.2 mL.kg ‐1.h ‐1 preceded by a bolus of 2 microg.kg ‐1 (CLON group)
Trial: 14698362
Drug: Clonidine 1
RxNorm normalized name: apraclonidine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 1 microg.mL ‐1 and ropivacaine 0.1% at rate of 0.2 mL.kg ‐1.h ‐1 (CLON+ROPIV group)
Trial: 10652960
Drug: Prednisolone plus
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone plus 15 mg of menatetrenone, three times per day (Group 2)
Trial: 8364946
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba extract (EGb 761) 320 mg
Trial: 8364946
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba extract (EGb 761) 600 mg
Trial: 2439787
Drug: bisoprolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bisoprolol (10 mg)
Trial: 29484546
Drug: 100-TGF (sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-TGF (sodium fluoride NaF associated with tara gum, 1100 mg/L)
Trial: 29484546
Drug: 50-TGF (50%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50-TGF (50% NaF associated with tara gum + 50% free NaF, 1100 mg/L)
Trial: 29484546
Drug: PC (free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC (free NaF, 1100 mg/L)
Trial: 27596550
Drug: Voglibose 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voglibose 0.2 mg for 3 times per day
Trial: 12859464
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl (50 microg single dose)
Trial: 12859464
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (50 microg single dose)
Trial: 8571910
Drug: 0.8 mg
RxNorm normalized name: biotin 0.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mg Fe/kg of AMI 227
Trial: 8571910
Drug: 1.1 mg
RxNorm normalized name: menthol 1.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.1 mg Fe/kg of AMI 227
Trial: 8571910
Drug: 1.7 mg
RxNorm normalized name: pectin 1.7 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.7 mg Fe/kg of AMI 227
Trial: 30531232
Drug: 9-week stabilization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9-week stabilization exercise therapy program, 60 mins/week
Trial: 25240992
Drug: Natural formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural formulation containing tea catechins
Trial: 17922560
Drug: UFT (tegafur-uracil)
RxNorm normalized name: UFT
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT (tegafur-uracil) plus leucovorin given as two daily doses (bid)
Trial: 17922560
Drug: UFT (tegafur-uracil)
RxNorm normalized name: UFT
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT (tegafur-uracil) plus leucovorin given as three daily doses (tid)
Trial: 10338458
Drug: High-dose transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose transdermal nitroglycerin (NTG) 50 to 100 mg daily for 12 hours
Trial: 6994786
Drug: Guanfacine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (3 mg daily)
Trial: 6994786
Drug: Guanethidine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanethidine (20 mg daily)
Trial: 20723033
Drug: Edoxaban 60
RxNorm normalized name: edoxaban 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 60 mg
Trial: 25739586
Drug: Insulin glulisine
RxNorm normalized name: Insulin Glulisine
DrugBank: Insulin glulisine (DB01309)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin glulisine (Glu)
Trial: 23932834
Drug: Acetaminophen (10-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (10-15 mg/kg/dose, PO) every 6h as necessary
Trial: 8520640
Drug: 4.2 MJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.2 MJ diet daily with exercise
Trial: 8520640
Drug: 4.2 MJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.2 MJ diet daily without exercise
Trial: 2146047
Drug: Danazol 600
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol 600 mg daily for 6 months
Trial: 2146047
Drug: Goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.6 mg monthly depot injections for 6 months
Trial: 386157
Drug: Methylprednisolone and
RxNorm normalized name: methylprednisolone and antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone and cyclophosphamide pretreatment (5 g each)
Trial: 31994303
Drug: 270 mg
RxNorm normalized name: leucine 270 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 270 mg ferrous sulphate twice a day (total elemental iron dose: 160 mg/day)
Trial: 31994303
Drug: 270 mg
RxNorm normalized name: leucine 270 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 270 mg ferrous sulphate once a day (total elemental iron dose: 80 mg/day)
Trial: 31994303
Drug: 270 mg
RxNorm normalized name: leucine 270 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 270 mg ferrous sulphate every other day (total elemental iron dose: 80 mg/every other day)
Trial: 23314603
Drug: Olanzapine 10
RxNorm normalized name: olanzapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10 mg orally daily for 3 days
Trial: 23314603
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg orally TID for 3 days
Trial: 11566255
Drug: Simvastatin and
RxNorm normalized name: simvastatin and ezetimibe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin and Niacin (S-N) therapy
Trial: 9502662
Drug: Aggressive tocolysis
RxNorm normalized name: ZO SKIN HEALTH Aggressive Anti-Aging Program KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive tocolysis with intravenous magnesium sulfate
Trial: 17472992
Drug: Sitaxsentan 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitaxsentan 100 mg or 300 mg daily
Trial: 9615797
Drug: Granulocyte/macrophage colony
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte/macrophage colony stimulating factor (GM-CSF), administered as subcutaneous injections for 7 consecutive days to 14 patients.
Trial: 9615797
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered as subcutaneous injections for 7 consecutive days to 15 patients.
Trial: 31533292
Drug: Qigong exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qigong exercise session (video demonstration via website), delivered twice a day for 12 consecutive weeks
Trial: 26083769
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of sodium diclofenac (50mg) once a day for 3 weeks.
Trial: 11386413
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) chemotherapy
Trial: 11386413
Drug: Standard-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (SD) chemotherapy
Trial: 8002509
Drug: Glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose infusion (0.5 g/min) after placebo (Pl)
Trial: 3201128
Drug: FF5005 (pectin-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF5005 (pectin-containing formulation)
Trial: 19721848
Drug: Acute tryptophan
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute tryptophan depletion (ATD) in women with bulimia using serotonin reuptake inhibitors
Trial: 19721848
Drug: Acute tryptophan
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute tryptophan depletion (ATD) in bulimic women not using medications
Trial: 17192328
Drug: orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: orlistat 120 mg t.i.d.
Trial: 15339330
Drug: Infliximab treatment
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab treatment (administered intravenously three times)
Trial: 15339330
Drug: Infliximab treatment
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab treatment (once)
Trial: 15381516
Drug: Manipulative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manipulative therapy
Trial: 9704239
Drug: Diet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet treatment in Northern California (NoCal)
Trial: 9704239
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment in Northern California (NoCal)
Trial: 9704239
Drug: Diet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet treatment in New England (NewEng)
Trial: 9704239
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment in New England (NewEng)
Trial: 8032580
Drug: Cadralazine 10
RxNorm normalized name: cadralazine
DrugBank: Cadralazine (DB13452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cadralazine 10 mg once daily
Trial: 7000296
Drug: Chlorthalidone 25
RxNorm normalized name: chlorthalidone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 25 mg once daily
Trial: 2681087
Drug: Parenteral prophylaxis
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral prophylaxis with cefazolin 1 g every 6 hours for 24 hours (2 g for knee-replacement)
Trial: 2681087
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of bone cement impregnated with antibiotics (e.g. Palacos-Gentamycin-cement)
Trial: 2681087
Drug: Antibiotic selection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic selection adjusted based on ongoing monitoring of antimicrobial resistance
Trial: 30374683
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg CBD twice daily
Trial: 30374683
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg CBD twice daily
Trial: 30374683
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg CBD single dose